Skip to main content
. 2019 Dec 6;7(3):344–355. doi: 10.1093/nop/npz063

Table 3.

Pretreatment Characteristics: Cerebral Metastasis

Variable No. of Patients %
Total 1048 100.0
Number of brain metastases
 • 1 541 51.6
 • 2 191 18.2
 • 3 93 8.9
 • 4 41 3.9
 • ≥ 5 162 15.5
 • LMD 3 < 0.3
 • NA 17 1.6
Sentinel location of lesions
 • Frontal lobe 406 38.7
 • Temporal lobe 79 7.5
 • Parietal lobe 153 14.6
 • Occipital lobe 96 9.2
 • Cerebellum 203 19.4
 • Brainstem 22 2.1
 • Durally based 15 1.4
 • Other 49 4.7
Size of sentinel metastasis, mm
 • ≤ 30 637 60.7
 • > 30 292 27.9
 • NA 119 11.4
Cranial imaging
 • CT head 635 60.6
 • MRI head 873 83.3
 • NA 13 1.2
Reason MRI not undertaken
 • Contraindicated 17 9.7
 • Patient unwilling 3 1.7
 • Indicated but not performed before MDT 91 52.0
 • No clinical indication 48 27.4
 • NA 16 9.1
MRI sequences
 • Gadolinium contrast 836 95.8
 • Navigation sequence 378 43.3
 • DTI 668 76.5
 • DWI 66 7.6
 • Spectroscopy 3 0.3
Prior brain surgery
 • Yes 154 14.7
 • No 891 85.0
 • NA 3 < 0.3

Abbreviations: DTI, diffusion tensor imaging; DWI, diffusion-weighted imaging; LDM, leptomeningeal disease MDT, multidisciplinary team meeting; NA, not available (unknown or not recorded).